New platelet blood test aims to improve prostate cancer detection

NCT ID NCT07144228

Recruiting now Diagnosis Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated Jun 15, 2026 · Updated 23 times

Summary

This study tests a new blood test that looks at proteins in platelets (a type of blood cell) to see if it can find prostate cancer more accurately than current methods like PSA tests and biopsies. Researchers at Duke University will enroll 300 men who are already being checked for prostate cancer. The test is low-risk, requiring only a few extra tubes of blood drawn during routine visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Duke University
RECRUITING

Durham, North Carolina, 27710, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

disease prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER (DIAGNOSIS)